DOW JONES27,081.36+0.00 0.00%
S&P 5003,128.21+0.00 0.00%
NASDAQ9,024.91+59.30 0.66%

Cantor Fitzgerald Maintains Neutral on Arrowhead Pharmaceuticals, Raises Price Target to $55

Cantor Fitzgerald analyst Alethia Young maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral and raises the price target from $50 to $55.

Benzinga · 02/06/2020 12:36

Cantor Fitzgerald analyst Alethia Young maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral and raises the price target from $50 to $55.